{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:29:53Z","timestamp":1771939793235,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Multiple myeloma (MM) is a clonal hematologic malignancy characterized by low rate of complete remissions. Cytokine-induced killer (CIK) cell therapy has shown promising benefits in MM treatment. In this study, we investigated whether the pro-inflammatory cytokines secreted by macrophages could upregulate MICA\/B expression and thus the cytotoxicity of CIK cells. Flow cytometry was used for phenotypic measurement and the cytotoxicity assay of CIK cells. Soluble MICA\/B and macrophage-derived cytokines were measured using ELISA assay. CCK-8 assay was applied to evaluate cell viabilities. Gene expression levels were investigated using RT-qPCR. The expression of MICA\/B and PD-L1 in MM cells was upregulated by pro-inflammatory cytokines. Pro-inflammatory cytokines enhanced the cytotoxicity of CIK cells against MM cells, with TNF-\u03b1 exhibiting a more potent effect than IL-1\u03b2 and IL-6 as it strengthened both components of the NKG2D-MICA\/B axis. PD-L1 blockade promoted the cytotoxic ability of CIK cells. Mechanistically, IL-1\u03b2, IL-6, and TNF-\u03b1 enhanced the transcription of MICA\/B and PD-L1 genes via the PI3K\/AKT, JAK\/STAT3, and MKK\/p38 MAPK pathways. Pro-inflammatory cytokines upregulated the expression of MICA\/B and PD-L1, thereby promoting the cytotoxicity of CIK cells against MM by strengthening the NKG2D pathway, while PD-L1 blockade enhanced the cytotoxicity of CIK cells.<\/jats:p>","DOI":"10.1038\/s41598-025-99289-x","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:05:18Z","timestamp":1747195518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Macrophage-derived pro-inflammatory cytokines augment the cytotoxicity of cytokine-induced killer cells by strengthening the NKG2D pathway in multiple myeloma"],"prefix":"10.1038","volume":"15","author":[{"given":"Peng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukacs-Kornek","family":"Veronika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Weiher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Gonzalez-Carmona","family":"Maria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo G. H.","family":"Schmidt-Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"99289_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan, A. J. et al. Diagnosis and management of multiple myeloma: a review. Jama 327, 464\u2013477 (2022).","journal-title":"Jama"},{"key":"99289_CR2","doi-asserted-by":"publisher","first-page":"14632","DOI":"10.3390\/ijms150814632","volume":"15","author":"FC Schmeel","year":"2014","unstructured":"Schmeel, F. C., Schmeel, L. C., Gast, S. M. & Schmidt-Wolf, I. G. Adoptive immunotherapy strategies with cytokine-induced killer (CIK) cells in the treatment of hematological malignancies. Int. J. Mol. Sci. 15, 14632\u201314648 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"99289_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40164-015-0027-9","volume":"4","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. The combination of dendritic cells-cytotoxic T lymphocytes\/cytokine-induced killer (DC-CTL\/CIK) therapy exerts immune and clinical responses in patients with malignant tumors. Exp. Hematol. Oncol. 4, 32. https:\/\/doi.org\/10.1186\/s40164-015-0027-9 (2015).","journal-title":"Exp. Hematol. Oncol."},{"key":"99289_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.174.1.139","volume":"174","author":"I Schmidt-Wolf","year":"1991","unstructured":"Schmidt-Wolf, I., Negrin, R. S., Kiem, H. P., Blume, K. G. & Weissman, I. L. Use of a SCID mouse\/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J. Exp. Med. 174, 139\u2013149 (1991).","journal-title":"J. Exp. Med."},{"key":"99289_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00432-014-1864-3","volume":"141","author":"LC Schmeel","year":"2015","unstructured":"Schmeel, L. C., Schmeel, F. C., Coch, C. & Schmidt-Wolf, I. G. Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC). J. Cancer Res. Clin. Oncol. 141, 839\u2013849. https:\/\/doi.org\/10.1007\/s00432-014-1864-3 (2015).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"99289_CR6","doi-asserted-by":"publisher","unstructured":"Introna, M. & Correnti, F. Innovative clinical perspectives for CIK cells in Cancer patients. Int. J. Mol. Sci. 19. https:\/\/doi.org\/10.3390\/ijms19020358 (2018).","DOI":"10.3390\/ijms19020358"},{"key":"99289_CR7","doi-asserted-by":"publisher","unstructured":"Wu, X., Zhang, Y., Li, Y. & Schmidt-Wolf, I. G. H. Increase of antitumoral effects of Cytokine-Induced killer cells by Antibody-Mediated Inhibition of MICA shedding. Cancers 12. https:\/\/doi.org\/10.3390\/cancers12071818 (2020).","DOI":"10.3390\/cancers12071818"},{"key":"99289_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","volume":"31","author":"DH Raulet","year":"2013","unstructured":"Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W. & Jung, H. Regulation of ligands for the NKG2D activating receptor. Annu. Rev. Immunol. 31, 413\u2013441. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095951 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"99289_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","volume":"8","author":"D Denk","year":"2022","unstructured":"Denk, D. & Greten, F. R. Inflammation: the incubator of the tumor microenvironment. Trends Cancer. 8, 901\u2013914. https:\/\/doi.org\/10.1016\/j.trecan.2022.07.002 (2022).","journal-title":"Trends Cancer"},{"key":"99289_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten, F. R. & Grivennikov, S. I. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51, 27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025 (2019).","journal-title":"Immunity"},{"key":"99289_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99289_CR12","doi-asserted-by":"publisher","first-page":"106939","DOI":"10.1016\/j.intimp.2020.106939","volume":"88","author":"L Li","year":"2020","unstructured":"Li, L. et al. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. Int. Immunopharmacol. 88, 106939. https:\/\/doi.org\/10.1016\/j.intimp.2020.106939 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"99289_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","volume":"120","author":"P Berraondo","year":"2019","unstructured":"Berraondo, P. et al. Cytokines in clinical cancer immunotherapy. Br. J. Cancer. 120, 6\u201315. https:\/\/doi.org\/10.1038\/s41416-018-0328-y (2019).","journal-title":"Br. J. Cancer"},{"key":"99289_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445\u2013455. https:\/\/doi.org\/10.1038\/nature12034 (2013).","journal-title":"Nature"},{"key":"99289_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/leu.2012.213","volume":"27","author":"H Tamura","year":"2013","unstructured":"Tamura, H. et al. Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma. Leukemia 27, 464\u2013472. https:\/\/doi.org\/10.1038\/leu.2012.213 (2013).","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"99289_CR16","doi-asserted-by":"publisher","first-page":"i104","DOI":"10.1136\/ard.2010.140145","volume":"70","author":"SI Grivennikov","year":"2011","unstructured":"Grivennikov, S. I. & Karin, M. Inflammatory cytokines in cancer: tumour necrosis factor and Interleukin 6 take the stage. Ann. Rheum. Dis. 70 (Suppl 1), i104\u2013108. https:\/\/doi.org\/10.1136\/ard.2010.140145 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"99289_CR17","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","volume":"81","author":"NR Anderson","year":"2021","unstructured":"Anderson, N. R., Minutolo, N. G., Gill, S. & Klichinsky, M. Macrophage-Based approaches for Cancer immunotherapy. Cancer Res. 81, 1201\u20131208. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-2990 (2021).","journal-title":"Cancer Res."},{"key":"99289_CR18","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam, A. et al. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 233, 6425\u20136440. https:\/\/doi.org\/10.1002\/jcp.26429 (2018).","journal-title":"J. Cell. Physiol."},{"key":"99289_CR19","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s00018-016-2166-5","volume":"73","author":"C Belgiovine","year":"2016","unstructured":"Belgiovine, C., D\u2019Incalci, M., Allavena, P. & Frapolli, R. Tumor-associated macrophages and anti-tumor therapies: complex links. Cell. Mol. Life Sci. 73, 2411\u20132424. https:\/\/doi.org\/10.1007\/s00018-016-2166-5 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"99289_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas, S. K. & Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889\u2013896. https:\/\/doi.org\/10.1038\/ni.1937 (2010).","journal-title":"Nat. Immunol."},{"key":"99289_CR21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/imm.13300","volume":"163","author":"VMT Bart","year":"2021","unstructured":"Bart, V. M. T., Pickering, R. J. & Taylor, P. R. Ipseiz, N. Macrophage reprogramming for therapy. Immunology 163, 128\u2013144. https:\/\/doi.org\/10.1111\/imm.13300 (2021).","journal-title":"Immunology"},{"key":"99289_CR22","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","volume":"74","author":"Y Zhu","year":"2014","unstructured":"Zhu, Y. et al. CSF1\/CSF1R Blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 74, 5057\u20135069. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3723 (2014).","journal-title":"Cancer Res."},{"key":"99289_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","volume":"539","author":"MM Kaneda","year":"2016","unstructured":"Kaneda, M. M. et al. PI3Kgamma is a molecular switch that controls immune suppression. Nature 539, 437\u2013442. https:\/\/doi.org\/10.1038\/nature19834 (2016).","journal-title":"Nature"},{"key":"99289_CR24","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm.3931","volume":"21","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. CD47 Blockade triggers T cell-mediated destruction of Immunogenic tumors. Nat. Med. 21, 1209\u20131215. https:\/\/doi.org\/10.1038\/nm.3931 (2015).","journal-title":"Nat. Med."},{"key":"99289_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.biomaterials.2016.09.034","volume":"112","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment. Biomaterials 112, 153\u2013163. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.09.034 (2017).","journal-title":"Biomaterials"},{"key":"99289_CR26","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla, K. & Singh, P. K. Metabolic regulation of macrophage polarization in Cancer. Trends Cancer. 5, 822\u2013834. https:\/\/doi.org\/10.1016\/j.trecan.2019.10.007 (2019).","journal-title":"Trends Cancer"},{"key":"99289_CR27","doi-asserted-by":"publisher","first-page":"690869","DOI":"10.3389\/fimmu.2021.690869","volume":"12","author":"H Cai","year":"2021","unstructured":"Cai, H., Zhang, Y., Wang, J. & Gu, J. Defects in macrophage reprogramming in Cancer therapy: the negative impact of PD-L1\/PD-1. Front. Immunol. 12, 690869. https:\/\/doi.org\/10.3389\/fimmu.2021.690869 (2021).","journal-title":"Front. Immunol."},{"key":"99289_CR28","doi-asserted-by":"publisher","unstructured":"Arora, L., Kumar, A. P., Arfuso, F., Chng, W. J. & Sethi, G. The role of signal transducer and activator of transcription 3 (STAT3) and its targeted Inhibition in hematological malignancies. Cancers . 10. https:\/\/doi.org\/10.3390\/cancers10090327 (2018).","DOI":"10.3390\/cancers10090327"},{"key":"99289_CR29","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nrd4281","volume":"13","author":"AA Samatar","year":"2014","unstructured":"Samatar, A. A. & Poulikakos, P. I. Targeting RAS-ERK signalling in cancer: promises and challenges. Nat. Rev. Drug Discov. 13, 928\u2013942. https:\/\/doi.org\/10.1038\/nrd4281 (2014).","journal-title":"Nat. Rev. Drug Discov"},{"key":"99289_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1158\/2159-8290.CD-18-1321","volume":"9","author":"R Yaeger","year":"2019","unstructured":"Yaeger, R. & Corcoran, R. B. Targeting alterations in the RAF-MEK pathway. Cancer Discov. 9, 329\u2013341. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-1321 (2019).","journal-title":"Cancer Discov"},{"key":"99289_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrc3860","volume":"15","author":"LM Thorpe","year":"2015","unstructured":"Thorpe, L. M., Yuzugullu, H. & Zhao, J. J. PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat. Rev. Cancer. 15, 7\u201324. https:\/\/doi.org\/10.1038\/nrc3860 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"99289_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson, D. E., O\u2019Keefe, R. A. & Grandis, J. R. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 15, 234\u2013248. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99289_CR33","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1182\/blood-2018-01-829424","volume":"132","author":"TL Song","year":"2018","unstructured":"Song, T. L. et al. Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer\/T-cell lymphoma. Blood 132, 1146\u20131158. https:\/\/doi.org\/10.1182\/blood-2018-01-829424 (2018).","journal-title":"Blood"},{"key":"99289_CR34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/1078-0432.CCR-12-2731","volume":"19","author":"X Jiang","year":"2013","unstructured":"Jiang, X., Zhou, J., Giobbie-Hurder, A., Wargo, J. & Hodi, F. S. The activation of MAPK in melanoma cells resistant to BRAF Inhibition promotes PD-L1 expression that is reversible by MEK and PI3K Inhibition. Clin. Cancer Res. 19, 598\u2013609. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-2731 (2013).","journal-title":"Clin. Cancer Res."},{"key":"99289_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","volume":"19","author":"H Yamaguchi","year":"2022","unstructured":"Yamaguchi, H., Hsu, J. M., Yang, W. H. & Hung, M. C. Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat. Rev. Clin. Oncol. 19, 287\u2013305. https:\/\/doi.org\/10.1038\/s41571-022-00601-9 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"99289_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1310-0","volume":"38","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J. Experimental Clin. Cancer Res. 38, 1\u201315 (2019).","journal-title":"J. Experimental Clin. Cancer Res."},{"key":"99289_CR37","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/art.39295","volume":"67","author":"L Cifaldi","year":"2015","unstructured":"Cifaldi, L. et al. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome. Arthritis Rheumatol. 67, 3037\u20133046. https:\/\/doi.org\/10.1002\/art.39295 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"99289_CR38","doi-asserted-by":"publisher","unstructured":"Nyiramana, M. M. et al. Sea hare Hydrolysate-Induced reduction of human Non-Small cell lung Cancer cell growth through regulation of macrophage polarization and Non-Apoptotic regulated cell death pathways. Cancers 12. https:\/\/doi.org\/10.3390\/cancers12030726 (2020).","DOI":"10.3390\/cancers12030726"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99289-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:00:38Z","timestamp":1757419238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99289-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99289"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99289-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16739"}}